Encellin
encellin.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$17.9M
3 rounds on record
Latest round
$9.9M
Venture round · Sep 2023 · 3 yr ago
Team
3
US Form 5500 (plan participants) · Dec 2025 · 0% in a year
Backers
1
How Women Invest
The money's age
Long since its last round
36 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 21
Partnership Encellin Partners with Breakthrough T1D to Advance Immune-Protected Cell Therapy for Type 1 Diabetes · tmcnet.com
Sep 20, 2023
Raised a round Venture round $9.9M · SEC Form D
Jun 28, 2019
Raised a round Venture round $2.1M · SEC Form D
2015
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2023 | $9.9M | — | SEC Form D |
| Seed | Aug 2021 | $5.9M | Khosla Ventures lead, SV Latam Capital lead | businesswire |
| Venture round | Jun 2019 | $2.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Encellin, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Crystal NyitrayExecutive Officer, DirectorSEC Form D
Grace WeiDirectorSEC Form D
Ronald MartellExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
How Women Invest Similar startupsby what they do, their industry and backers
Terrestrial is transforming the delivery of next-generation therapies, starting with GLP-1. Terrestrial.
Without Energy is a venture-backed university spinout advancing next-generation power technology.
Constructive Bio designs and manufactures new-to-nature chemistries for next-generation therapies and materials.
Harnessing the power of allosteric modulators to design targeted, next-generation therapies for complex neuropsychiatric disorders.
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related…
AAVantgarde is a clinical-stage biotechnology company developing next-generation therapies for inherited retinal diseases with high unmet…
News
Encellin Partners with Breakthrough T1D to Advance Immune-Protected Cell Therapy for Type 1 Diabetes
SAN FRANCISCO & NEW YORK & MONTREAL, September 22, 2026--Encellin, Inc., a clinical-stage biotechnology company developing Encapsulated Cell Replacement Therapy (ENCRT), today announced a partnership with Breakthrough T1D, the leading global Type 1 Diabet
Read more
Report
Report
Encellin Partners with Breakthrough T1D to Advance Immune-Protected Cell Therapy for Type 1 Diabetes
Read more
Report
Encellin Announces Interim Clinical Results Showing First-in-Human Non-Fibrotic Engraftment and Viable Encapsulated Human Islets in Subjects with Type 1 Diabetes
SAN FRANCISCO, January 06, 2026--Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in study subjects with Type
Read more
Report
reported positive interim results
On January 6th, 2026, Encellin reported positive interim results of its Phase 1 clinical trial of encapsulated islets in people with type 1 diabetes (T1D).
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Crystal Nyitray
Executive Officer, Director
Grace Wei
Director
Ronald Martell
Executive Officer, Director
Maria del Consuelo Valverde
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
10-50 est. staff